BACKGROUND AND OBJECTIVES: Recent surveys confirm continued increases in the use of electronic-cigarettes (e-cigarettes) in adolescents and adults. Users often state that e-cigarettes reduce tobacco craving and withdrawal symptoms in addition to their smoking. Data from laboratory studies and clinical trials have confirmed these statements, though there are inconsistencies in the outcomes. In this pilot study, we set out to evaluate the effects of e-cigarettes, as compared to the participants' own cigarettes, on baseline craving and smoking severity. METHODS: Using a within-subjects, placebo-controlled study design, 15 tobacco-dependent, e-cigarette naïve participants sustained abstinence overnight. They completed distinct phases of this protocol during four separate study sessions. Participants were randomized to an e-cigarette device containing one of three doses of nicotine (0, 18, or 36 mg/ml) or their own cigarette. Each study visit was ~3 hours long and separated by at least 7 days. Visits included assessments of craving and smoking severity. RESULTS: The data showed that after 10 puffs in both the Own cigarette and e-cigarette conditions, breath carbon monoxide levels increased significantly in the former but not the latter. Questionnaire of Smoking Urges and Choices to Smoke scores were not statistically different across groups after two distinct bouts of 10 puffs each. Additionally, E-cigarette Perceptions Questionnaire responses were not significantly different according to dose. CONCLUSION AND SCIENTIFIC SIGNIFICANCE: This experiment provides data demonstrating that e-cigarettes did not reduce craving or smoking severity in e-cigarette naïve users. However, since this was a pilot study, the conclusions that can be drawn are limited. (Am J Addict 2019;28:361-366).
BACKGROUND AND OBJECTIVES: Recent surveys confirm continued increases in the use of electronic-cigarettes (e-cigarettes) in adolescents and adults. Users often state that e-cigarettes reduce tobacco craving and withdrawal symptoms in addition to their smoking. Data from laboratory studies and clinical trials have confirmed these statements, though there are inconsistencies in the outcomes. In this pilot study, we set out to evaluate the effects of e-cigarettes, as compared to the participants' own cigarettes, on baseline craving and smoking severity. METHODS: Using a within-subjects, placebo-controlled study design, 15 tobacco-dependent, e-cigarette naïve participants sustained abstinence overnight. They completed distinct phases of this protocol during four separate study sessions. Participants were randomized to an e-cigarette device containing one of three doses of nicotine (0, 18, or 36 mg/ml) or their own cigarette. Each study visit was ~3 hours long and separated by at least 7 days. Visits included assessments of craving and smoking severity. RESULTS: The data showed that after 10 puffs in both the Own cigarette and e-cigarette conditions, breath carbon monoxide levels increased significantly in the former but not the latter. Questionnaire of Smoking Urges and Choices to Smoke scores were not statistically different across groups after two distinct bouts of 10 puffs each. Additionally, E-cigarette Perceptions Questionnaire responses were not significantly different according to dose. CONCLUSION AND SCIENTIFIC SIGNIFICANCE: This experiment provides data demonstrating that e-cigarettes did not reduce craving or smoking severity in e-cigarette naïve users. However, since this was a pilot study, the conclusions that can be drawn are limited. (Am J Addict 2019;28:361-366).
Authors: Andrea R Vansickel; Caroline O Cobb; Michael F Weaver; Thomas E Eissenberg Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-07-20 Impact factor: 4.254
Authors: Kristy L Marynak; Doris G Gammon; Brian A King; Brett R Loomis; Erika B Fulmer; Teresa W Wang; Todd Rogers Journal: Am J Prev Med Date: 2017-03-09 Impact factor: 5.043
Authors: Robert F Leeman; Stephanie S O'Malley; Marney A White; Sherry A McKee Journal: Psychopharmacology (Berl) Date: 2010-06-29 Impact factor: 4.530
Authors: Neal L Benowitz; Katherine M Dains; Delia Dempsey; Margaret Wilson; Peyton Jacob Journal: Nicotine Tob Res Date: 2011-05-05 Impact factor: 4.244
Authors: Paul Faulkner; Dara G Ghahremani; Rachel F Tyndale; Chelsea M Cox; Ari S Kazanjian; Neil Paterson; Shahrdad Lotfipour; Gerhard S Hellemann; Nicole Petersen; Celia Vigil; Edythe D London Journal: Neuropsychopharmacology Date: 2017-01-24 Impact factor: 7.853
Authors: Andrea C Villanti; Lauren K Collins; Raymond S Niaura; Stacey Y Gagosian; David B Abrams Journal: BMC Public Health Date: 2017-12-29 Impact factor: 3.295